UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

GED-0507 attenuates lung fibrosis by counteracting myofibroblast transdifferentiation in vivo and in vitro

PloS one, 2021-09, Vol.16 (9), p.e0257281-e0257281

2021

Volltextzugriff (PDF)

S1199 Tofacitinib in Ulcerative Colitis: The Relationship Between OCTAVE Induction Week 8 Symptomatic Remission and OCTAVE Sustain Week 52 Remission

The American journal of gastroenterology, 2023-10, Vol.118 (10S), p.S914-S915

2023

Volltextzugriff (PDF)

Targeting Peroxisome Proliferator-Activated Receptors (PPARs): Development of Modulators

Journal of medicinal chemistry, 2012-05, Vol.55 (9), p.4027-4061

2012

Volltextzugriff (PDF)

CEACAM6 acts as a receptor for adherent-invasive E. coli, supporting ileal mucosa colonization in Crohn disease

The Journal of clinical investigation, 2007-06, Vol.117 (6), p.1566-1574

2007

Volltextzugriff (PDF)

Novel PPARγ Modulator GED-0507-34 Levo Ameliorates Inflammation-driven Intestinal Fibrosis

Inflammatory bowel diseases, 2016-02, Vol.22 (2), p.279-292

2016

Volltextzugriff (PDF)

Ustekinumab Serum Trough Levels May Identify Suboptimal Responders to Ustekinumab in Crohn’s Disease

Digestive diseases and sciences, 2020-05, Vol.65 (5), p.1445-1452

2020

Volltextzugriff (PDF)

Natural History of Eosinophilic Gastroenteritis

Clinical gastroenterology and hepatology, 2011-11, Vol.9 (11), p.950-956.e1

2011

Volltextzugriff (PDF)

Adaptive Prior Selection for Repertoire-Based Online Adaptation in Robotics

Frontiers in robotics and AI, 2020-01, Vol.6, p.151-151

2020

Volltextzugriff (PDF)

GED-0507 is a novel potential antifibrotic treatment option for pulmonary fibrosis

Cellular & molecular immunology, 2020-12, Vol.17 (12), p.1272-1274

2020

Volltextzugriff (PDF)

A Synbiotic Combining Chitin-Glucan and Lactobacillus acidophilus NCFM Induces a Colonic Molecular Signature Soothing Intestinal Pain and Inflammation in an Animal Model of IBS

International journal of molecular sciences, 2024-10, Vol.25 (19), p.10732

2024

Volltextzugriff (PDF)

Role of glycogen synthase kinase-3β and PPAR-γ on epithelial-to-mesenchymal transition in DSS-induced colorectal fibrosis

PloS one, 2017-02, Vol.12 (2), p.e0171093-e0171093

2017

Volltextzugriff (PDF)

Radiological Response Is Associated with Better Outcomes and Should Be Considered a Therapeutic Target in Crohn’s Disease

Digestive diseases and sciences, 2020-09, Vol.65 (9), p.2664-2674

2020

Volltextzugriff (PDF)

Changes in HLA-B27 Transgenic Rat Fecal Microbiota Following Tofacitinib Treatment and Ileocecal Resection Surgery: Implications for Crohn's Disease Management

International journal of molecular sciences, 2024-02, Vol.25 (4), p.2164

2024

Volltextzugriff (PDF)

Effects of urban coarse particles inhalation on oxidative and inflammatory parameters in the mouse lung and colon

Particle and fibre toxicology, 2017-11, Vol.14 (1), p.46-46, Article 46

2017

Volltextzugriff (PDF)

PPAR-gamma in ulcerative colitis: a novel target for intervention

Current drug targets, 2013-11, Vol.14 (12), p.1501-1507

2013

Volltextzugriff (PDF)

Taxonomic and phenotypic analysis of bifidobacteria isolated from IBD patients as potential probiotic strains

BMC microbiology, 2024-06, Vol.24 (1), p.233-18, Article 233

2024

Volltextzugriff (PDF)

Treatment with P28GST, a schistosome-derived enzyme, after acute colitis induction in mice: Decrease of intestinal inflammation associated with a down regulation of Th1/Th17 responses

PloS one, 2018-12, Vol.13 (12), p.e0209681-e0209681

2018

Volltextzugriff (PDF)

Saccharomyces cerevisiae CNCM I-3856 in irritable bowel syndrome: An individual subject meta-analysis

World journal of gastroenterology : WJG, 2017-01, Vol.23 (2), p.336-344

2017

Volltextzugriff (PDF)

Peroxisome proliferator-activated receptor gamma activation is required for maintenance of innate antimicrobial immunity in the colon

Proceedings of the National Academy of Sciences - PNAS, 2010-05, Vol.107 (19), p.8772-8777

2010

Volltextzugriff (PDF)

Visceral fat and gut inflammation

Nutrition (Burbank, Los Angeles County, Calif.), 2012-02, Vol.28 (2), p.113-117

2012

Volltextzugriff (PDF)

Glugacon-like peptide-2: broad receptor expression, limited therapeutic effect on intestinal inflammation and novel role in liver regeneration

American journal of physiology: Gastrointestinal and liver physiology, 2014-08, Vol.307 (3), p.G274-G285

2014

Volltextzugriff (PDF)

Delivery of a mucin domain enriched in cysteine residues strengthens the intestinal mucous barrier

Scientific reports, 2015-05, Vol.5 (1), p.9577-9577, Article 9577

2015

Volltextzugriff (PDF)

Adherent invasive Escherichia coli (AIEC) strain LF82, but not Candida albicans, plays a profibrogenic role in the intestine

Gut pathogens, 2021-01, Vol.13 (1), p.5-5, Article 5

2021

Volltextzugriff (PDF)

Probiotic Yeast Therapy for Irritable Bowel Syndrome

Journal of neurogastroenterology and motility, 2016-07, Vol.22 (3), p.542-542

2016

Volltextzugriff (PDF)

LRH-1-mediated glucocorticoid synthesis in enterocytes protects against inflammatory bowel disease

Proceedings of the National Academy of Sciences - PNAS, 2007-08, Vol.104 (32), p.13098-13103

2007

Volltextzugriff (PDF)

1 – 25 von 364

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(312)
Mit Volltextzugriff
(315)

Publikationsform

Sprache

Englisch
(309)
Französisch
(55)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

GED-0507 attenuates lung fibrosis by counteracting myofibroblast transdifferentiation in vivo and in vitro

S1199 Tofacitinib in Ulcerative Colitis: The Relationship Between OCTAVE Induction Week 8 Symptomatic Remission and OCTAVE Sustain Week 52 Remission

Targeting Peroxisome Proliferator-Activated Receptors (PPARs): Development of Modulators

CEACAM6 acts as a receptor for adherent-invasive E. coli, supporting ileal mucosa colonization in Crohn disease

Novel PPARγ Modulator GED-0507-34 Levo Ameliorates Inflammation-driven Intestinal Fibrosis

Ustekinumab Serum Trough Levels May Identify Suboptimal Responders to Ustekinumab in Crohn’s Disease

Natural History of Eosinophilic Gastroenteritis

Adaptive Prior Selection for Repertoire-Based Online Adaptation in Robotics

GED-0507 is a novel potential antifibrotic treatment option for pulmonary fibrosis

A Synbiotic Combining Chitin-Glucan and Lactobacillus acidophilus NCFM Induces a Colonic Molecular Signature Soothing Intestinal Pain and Inflammation in an Animal Model of IBS

Role of glycogen synthase kinase-3β and PPAR-γ on epithelial-to-mesenchymal transition in DSS-induced colorectal fibrosis

Radiological Response Is Associated with Better Outcomes and Should Be Considered a Therapeutic Target in Crohn’s Disease

Changes in HLA-B27 Transgenic Rat Fecal Microbiota Following Tofacitinib Treatment and Ileocecal Resection Surgery: Implications for Crohn's Disease Management

Effects of urban coarse particles inhalation on oxidative and inflammatory parameters in the mouse lung and colon

PPAR-gamma in ulcerative colitis: a novel target for intervention

Taxonomic and phenotypic analysis of bifidobacteria isolated from IBD patients as potential probiotic strains

Treatment with P28GST, a schistosome-derived enzyme, after acute colitis induction in mice: Decrease of intestinal inflammation associated with a down regulation of Th1/Th17 responses

Saccharomyces cerevisiae CNCM I-3856 in irritable bowel syndrome: An individual subject meta-analysis

Peroxisome proliferator-activated receptor gamma activation is required for maintenance of innate antimicrobial immunity in the colon

Visceral fat and gut inflammation

Glugacon-like peptide-2: broad receptor expression, limited therapeutic effect on intestinal inflammation and novel role in liver regeneration

Delivery of a mucin domain enriched in cysteine residues strengthens the intestinal mucous barrier

Adherent invasive Escherichia coli (AIEC) strain LF82, but not Candida albicans, plays a profibrogenic role in the intestine

Probiotic Yeast Therapy for Irritable Bowel Syndrome

LRH-1-mediated glucocorticoid synthesis in enterocytes protects against inflammatory bowel disease

Suchergebnisse filtern